Clinical Trial Update: TRACK-TBI Longitudinal Biomarker Study

View source ↗

Summary

TRACK-TBI is a longitudinal biomarker study for traumatic brain injury. The current status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: University of Pennsylvania | Conditions: Traumatic Brain Injury | Status: ACTIVE_NOT_RECRUITING